Current Rating Overview
MarketsMOJO’s Strong Sell rating for Paushak Ltd is based on a comprehensive evaluation of four key parameters: Quality, Valuation, Financial Trend, and Technicals. This rating indicates that the stock is expected to underperform the broader market and peers, signalling caution for investors considering exposure to this microcap specialty chemicals company.
Quality Assessment
As of 20 March 2026, Paushak Ltd’s quality grade is assessed as average. Over the past five years, the company has demonstrated modest growth in net sales at an annualised rate of 10.41%, while operating profit growth has been notably weaker at 2.80% per annum. This sluggish operational expansion suggests limited competitive advantage or innovation within its niche. Furthermore, the company’s return on capital employed (ROCE) has declined, with the half-year figure at a low 10.47%, indicating suboptimal efficiency in generating profits from its capital base.
Valuation Considerations
The valuation grade for Paushak Ltd is very expensive. Despite its microcap status, the stock trades at a premium with an enterprise value to capital employed ratio of 2. This elevated valuation is not supported by the company’s fundamentals, as profits have contracted by 37.3% over the past year. The disparity between price and performance suggests that investors are paying a high price for limited earnings power, increasing downside risk if operational challenges persist.
Financial Trend and Profitability
The financial trend for Paushak Ltd is very negative. The latest data as of 20 March 2026 shows a significant decline in net sales by 16.98%, accompanied by two consecutive quarters of negative results. Quarterly profit after tax (PAT) has fallen sharply by 45.8% compared to the previous four-quarter average, with the most recent PAT at ₹6.17 crores. Additionally, the company’s debtor turnover ratio has deteriorated to 3.83 times, signalling potential issues in receivables management and cash flow. These factors collectively point to weakening financial health and operational stress.
Technical Analysis
Technically, the stock is rated bearish. Over the past year, Paushak Ltd has delivered a negative return of 9.46%, with sharper declines over shorter periods: -17.00% in one month and -30.51% over three months. The stock has consistently underperformed the BSE500 benchmark across the last three annual periods, reflecting persistent downward momentum. The recent day’s price movement showed a modest gain of 2.25%, but this is insufficient to offset the broader negative trend.
Additional Market Insights
Paushak Ltd’s microcap status and poor recent performance have resulted in negligible interest from domestic mutual funds, which currently hold 0% of the company. Given their capacity for detailed research and due diligence, this absence of institutional backing may indicate concerns about the company’s valuation or business prospects. The stock’s consistent underperformance relative to peers and benchmarks further reinforces the cautious stance.
Implications for Investors
The Strong Sell rating reflects a combination of weak financial results, expensive valuation, and negative technical signals. For investors, this suggests that Paushak Ltd currently carries elevated risk with limited upside potential. Those holding the stock may consider reducing exposure, while prospective investors should approach with caution and seek more favourable entry points or alternative opportunities within the specialty chemicals sector.
Only 1% make it here. This Large Cap from the Gems, Jewellery And Watches sector passed our rigorous filters with flying colors. Be among the first few to spot this gem!
- - Highest rated stock selection
- - Multi-parameter screening cleared
- - Large Cap quality pick
Summary of Key Metrics as of 20 March 2026
Paushak Ltd’s stock returns over various periods highlight the ongoing challenges: a 1-day gain of 2.25%, but declines of 0.58% over one week, 17.00% over one month, and 30.51% over three months. The six-month return is deeply negative at -47.40%, with year-to-date losses of 30.44%. Over the past year, the stock has fallen by 9.46%, underperforming the broader market consistently.
The company’s financial dashboard reveals poor long-term growth, with net sales increasing at just over 10% annually and operating profit growth lagging at 2.80%. The recent negative quarterly results and falling profitability metrics underscore the deteriorating business environment. The ROCE of 8.9% and a high valuation multiple further compound concerns about the stock’s risk-reward profile.
Investors should weigh these factors carefully when considering Paushak Ltd, recognising that the Strong Sell rating reflects a comprehensive assessment of current challenges and limited near-term recovery prospects.
Looking Ahead
While the company operates in the specialty chemicals sector, which can offer growth opportunities, Paushak Ltd’s current fundamentals and market performance suggest that it is not well positioned to capitalise on sector tailwinds at present. Investors seeking exposure to this industry may find more attractive risk-adjusted opportunities elsewhere until Paushak Ltd demonstrates a clear turnaround in financial health and valuation alignment.
Conclusion
Paushak Ltd’s Strong Sell rating by MarketsMOJO, last updated on 30 December 2025, is supported by the latest data as of 20 March 2026. The combination of average quality, very expensive valuation, very negative financial trends, and bearish technicals presents a compelling case for caution. Investors should consider this rating as a signal to reassess their holdings and investment strategies regarding this stock.
Get Started for only Rs. 16,999 - Get MojoOne for 2 Years + 1 Year Absolutely FREE! (72% Off) Start Today
